XML 55 R48.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Quarterly Data (Unaudited) (Tables)
 12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Quarterly Financial Information Disclosure [Abstract]    
Quarterly Data (Unaudited) Table
 
 
2019
 
 
First
 
Second
 
Third
 
Fourth
 
Total
 
 
(In Millions, Except Per Share Data)
Net operating revenues
 
$
1,124.0

 
$
1,135.0

 
$
1,161.6

 
$
1,184.4

 
$
4,605.0

Operating earnings (a)
 
167.1

 
152.6

 
151.2

 
141.2

 
612.1

Provision for income tax expense
 
30.8

 
23.5

 
34.3

 
27.3

 
115.9

Income from continuing operations
 
125.7

 
111.0

 
119.5

 
90.2

 
446.4

Loss from discontinued operations, net of tax
 
(0.5
)
 
(0.1
)
 
—

 
—

 
(0.6
)
Net income
 
125.2

 
110.9

 
119.5

 
90.2

 
445.8

Less: Net income attributable to noncontrolling interests
 
(22.9
)
 
(19.7
)
 
(21.9
)
 
(22.6
)
 
(87.1
)
Net income attributable to Encompass Health
 
$
102.3

 
$
91.2

 
$
97.6

 
$
67.6

 
$
358.7

Earnings per common share:
 
 
 
 
 
 
 
 
 
 
Basic earnings per share attributable to Encompass Health common shareholders: (b)
 
 
 
 
 
 
 
 
 
 
Continuing operations
 
$
1.05

 
$
0.93

 
$
0.99

 
$
0.69

 
$
3.66

Discontinued operations
 
(0.01
)
 
—

 
—

 
—

 
(0.01
)
Net income
 
$
1.04

 
$
0.93

 
$
0.99

 
$
0.69

 
$
3.65

Diluted earnings per share attributable to Encompass Health common shareholders: (b)
 
 
 
 
 
 
 
 
 
 
Continuing operations
 
$
1.04

 
$
0.92

 
$
0.98

 
$
0.68

 
$
3.62

Discontinued operations
 
(0.01
)
 
—

 
—

 
—

 
(0.01
)
Net income
 
$
1.03

 
$
0.92

 
$
0.98

 
$
0.68

 
$
3.61


(a) 
We define operating earnings as income from continuing operations attributable to Encompass Health before (1) loss on early extinguishment of debt; (2) interest expense and amortization of debt discounts and fees; (3) other income; and (4) income tax expense.
(b)  
Per share amounts may not sum due to the weighted average common shares outstanding during each quarter compared to the weighted average common shares outstanding during the entire year.
 
 
2018
 
 
First
 
Second
 
Third
 
Fourth
 
Total
 
 
(In Millions, Except Per Share Data)
Net operating revenues
 
$
1,046.0

 
$
1,067.7

 
$
1,067.6

 
$
1,096.0

 
$
4,277.3

Operating earnings (a)
 
150.0

 
157.3

 
154.5

 
93.4

 
555.2

Provision for income tax expense
 
30.0

 
29.3

 
30.2

 
29.4

 
118.9

Income from continuing operations
 
105.7

 
113.0

 
109.4

 
46.2

 
374.3

(Loss) income from discontinued operations, net of tax
 
(0.5
)
 
0.2

 
(0.1
)
 
1.5

 
1.1

Net income
 
105.2

 
113.2

 
109.3

 
47.7

 
375.4

Less: Net income attributable to noncontrolling interests
 
(21.4
)
 
(21.4
)
 
(20.7
)
 
(19.6
)
 
(83.1
)
Net income attributable to Encompass Health
 
$
83.8

 
$
91.8

 
$
88.6

 
$
28.1

 
$
292.3

Earnings per common share:
 
 
 
 
 
 
 
 
 
 
Basic earnings per share attributable to Encompass Health common shareholders: (b)
 
 
 
 
 
 
 
 
 
 
Continuing operations
 
$
0.86

 
$
0.93

 
$
0.90

 
$
0.27

 
$
2.97

Discontinued operations
 
(0.01
)
 
—

 
—

 
0.02

 
0.01

Net income
 
$
0.85

 
$
0.93

 
$
0.90

 
$
0.29

 
$
2.98

Diluted earnings per share attributable to Encompass Health common shareholders: (b)
 
 
 
 
 
 
 
 
 
 
Continuing operations
 
$
0.85

 
$
0.92

 
$
0.89

 
$
0.26

 
$
2.92

Discontinued operations
 
(0.01
)
 
—

 
—

 
0.02

 
0.01

Net income
 
$
0.84

 
$
0.92

 
$
0.89

 
$
0.28

 
$
2.93


(a) 
We define operating earnings as income from continuing operations attributable to Encompass Health before (1) loss on early extinguishment of debt; (2) interest expense and amortization of debt discounts and fees; (3) other income; and (4) income tax expense.
(b)  
Per share amounts may not sum due to the weighted average common shares outstanding during each quarter compared to the weighted average common shares outstanding during the entire year.